Advertisement
Bavarian Nordic A/S (BVNRY)
OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Follow
As of 03:56PM EST. Market open.
| Previous Close | 10.07 |
| Open | 9.64 |
| Bid | 9.73 x 46000 |
| Ask | 9.77 x 46000 |
| Day's Range | 9.47 - 9.64 |
| 52 Week Range | 9.47 - 14.60 |
| Volume | |
| Avg. Volume | 94,911 |
| Market Cap | 2.369B |
| Beta (5Y Monthly) | 1.58 |
| PE Ratio (TTM) | 21.66 |
| EPS (TTM) | 0.44 |
| Earnings Date | Nov 15, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Mar 27, 2020 |
| 1y Target Est | N/A |
Clinical Trials ArenaBavarian Nordic’s mpox vaccine to be trialled in pregnant women and infants
Pregnant women and infants are at risk should they contract mpox but there are no approved vaccines for this population.
ZacksIs Bavarian Nordic (BVNRY) Stock Outpacing Its Medical Peers This Year?
Here is how Bavarian Nordic (BVNRY) and Dare Bioscience, Inc. (DARE) have performed compared to their sector so far this year.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.